LY303870, a centrally active neurokinin-1 antagonist with a long duration of action.

Autor: S, Iyengar, A, Hipskind P, R, Gehlert D, D, Schober, L, Lobb K, A, Nixon J, R, Helton D, J, Kallman M, S, Boucher, R, Couture, L, Li D, M, Simmons R

Publikováno v: The Journal of Pharmacology and Experimental Therapeutics; February 1997, Vol. 280 Issue: 2 p774-85, 12p